Skip to content
Medical Health Aged Care

Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery

Syndesis Health 3 mins read

NEW YORK, NY / ACCESSWIRE / September 19, 2023 / InSyBio, a leading biotechnology company that has developed a suite of advanced AI tools for biomarker discovery in clinical and multi-omics data, has announced a strategic partnership with Syndesis Health, a leader in global real-world evidence. The partnership aims to leverage the clinical and genomic data on Syntium, Syndesis' data platform of global healthcare data, to accelerate research and development in several therapeutic areas, including cardiovascular health, oncology, and rare diseases.

The importance of biomarkers

Biomarkers are body characteristics that can be measured, such as the biological molecules found in bodily fluids or tissues, including DNA, antibodies, proteins, or other smaller molecules. They are necessary to predict the effectiveness of drugs and patient outcomes; however, biomarker discovery is a very complex and costly process that often results in poor or inaccurate outcomes due to the use of disparate tools and datasets, and the high complexity of high-throughput -omics data.

InSyBio's platform simplifies and accelerates the process of biomarker discovery by providing a single, highly accurate, and effective processing pipeline that uses machine learning to analyze biodata. Syntium's longitudinal datasets, which include clinical, genomic, and other data, are ideal for applying InSyBio's suite of tools in biomarker discovery. Combining Syntium data with InSyBio's platform will create a unique opportunity for biopharma and diagnostic companies to uncover breakthrough discoveries with the potential to vastly improve global patient outcomes.

"Precision medicine is still in its infancy and many patients are misdiagnosed or do not get the most beneficial treatment for them. The wealth of Syntium's data sets when harnessed by our automatic AI-driven technology holds the potential to upend the medical field practices, and highly impact overall healthcare quality at national and international levels. We are looking forward to working with the innovative team of Syndesis Health," said Labros Digonis, InSyBio CEO.

"We are incredibly excited to embark on this partnership with InSyBio to enable biomarker discovery for cutting-edge healthcare innovation," said Josh Sutton, Syndesis Health CEO. "Together we seek to raise the bar for global health research and innovation in service of patients worldwide."

About Syndesis Health

Syndesis Health is the data and technology catalyst to a multi-continent network of healthcare and life sciences organizations. Its primary aim is to enhance global health outcomes and equity through its secure data platform, Syntium, and the Syndesis Health Network, a member community promoting research collaboration, information sharing, and access to common tools.

About InSyBio

InSyBio is an international pioneer biotechnology company revolutionizing the medical field through targeted biomarker discovery, highly accurate predictive analytics and the development of personalization tests for drugs. Its solutions provide the R&D departments of Pharma and Research Institutes with the means to meet their most challenging research and innovation goals. This is done through a sophisticated, software-as-a-service, machine learning platform, which comprehensively integrates multi-omics and clinical data, thus reducing the number of samples and additional validation experiments needed.

Contact Information

Leah Patterson
Chief Marketing Officer
[email protected]
+1.646.274.1420

SOURCE: Syndesis Health

.


View source version on accesswire.com:
https://www.accesswire.com/785152/syndesis-health-and-insybio-partner-in-predictive-modelling-and-biomarker-discovery

More from this category

  • Medical Health Aged Care
  • 17/05/2025
  • 03:56
Clue

MIT, University of Colorado Denver, and Clue App Publish Largest Women’s Health Study Documenting Air Pollution’s Impact on Menstrual Cycles

Analysis of 2.2 million menstrual cycles tracked in Clue shows connection between pollution exposure and reproductive healthCAMBRIDGE, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- Researchers at MIT’s Senseable City Lab and the University of Colorado Denver, in collaboration with the Clue app, have published the largest study of its kind examining the impact of air pollution on menstrual health across multiple countries. The research, just published in The Lancet Planetary Health, analyzed data from 2.2 million menstrual cycles tracked in Clue, across 230 cities in the United States, Mexico, and Brazil. The study found that higher concentrations of fine particulate…

  • Medical Health Aged Care
  • 16/05/2025
  • 13:17
Dementia Australia

On this weekend – Memory Walk & Jog Melbourne!

The 2025 Melbourne Memory Walk & Jog is upon us, with the much-anticipated event taking place this weekend on Sunday 18 May at Princes Park, Carlton North. Starting at 7:30am, we welcome everyone in the Melbourne community to join fellow participants as they walk, jog or run for better brain health and to help raise money in support of people living with dementia, their families and carers. Join MC’s Woody Whitelaw and Takaya Honda for a wonderful fun, family friendly day out. More than 2,260 people have already signed-up to take part – but there’s always room for more with…

  • Contains:
  • Medical Health Aged Care
  • 16/05/2025
  • 12:01
Dementia Australia

National radio host Woody Whitelaw named Dementia Australia Ambassador to champion dementia awareness

Dementia Australia is proud to welcome Woody Whitelaw as its newest Ambassador ahead of the Melbourne Memory Walk & Jog on Sunday 18 May. Woody, who co-hosts the KIIS FM national radio drive show Will & Woody, has a strong personal connection to dementia, with all four of his grandparents having lived with the condition. Over the past two years, he has consistently demonstrated his commitment to raising awareness and showing support for people impacted by dementia. “Dementia has touched every part of my family – all four of my grandparents lived with it,” Mr Whitelaw said. “After seeing what…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.